carbimazole has been researched along with Sepsis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Er, C; Sule, AA | 1 |
| Lynch, MJ; Woodford, NW | 1 |
| Christ-Crain, M; Eriksson, U; Miller, B; Schuetz, P; Zulewski, H | 1 |
3 other study(ies) available for carbimazole and Sepsis
| Article | Year |
|---|---|
Cholestyramine as monotherapy for Graves' hyperthyroidism.
Topics: Adult; Carbimazole; China; Cholestyramine Resin; Female; Graves Disease; Humans; Hyperthyroidism; Patient Admission; Sepsis; Thyroid Gland; Treatment Outcome | 2016 |
Fatality complicating agranulocytosis in the setting of carbimazole therapy.
Topics: Agranulocytosis; Antithyroid Agents; Carbimazole; Fatal Outcome; Female; Forensic Pathology; Graves Disease; Humans; Middle Aged; Pancytopenia; Pseudomonas Infections; Sepsis | 2008 |
[Amiodarone-induced thyrotoxicosis: a diagnostic and therapeutic challenge].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Atrial Flutter; Carbimazole; Diagnosis, Differential; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Middle Aged; Neutropenia; Sepsis; Thyroid Function Tests; Thyroidectomy; Thyrotoxicosis | 2005 |